Faruqi & Faruqi, LLP Announces Investigation of China Medicine Corp.

Faruqi & Faruqi, LLP, a national law firm concentrating on investor rights, consumer rights and enforcement of federal antitrust laws, is investigating potential wrongdoing at China Medicine Corp. (“China Medicine” or the “Company”) (OTC: CHME). Faruqi & Faruqi, LLP seeks to determine whether China Medicine violated federal securities laws in connection with statements made to the Company’s shareholders.

Request more information now by clicking here: www.faruqilaw.com/CHME

The investigation focuses on whether certain individuals violated federal securities laws by, among other things, failing to disclose that: (1) the Company’s employees where engaged in improper activities with respect to financial reporting; (2) the financial reports filed by the Company with the SEC and related statements to investors were materially inaccurate and unreliable; and (3) the Company’s accountant failed to conduct its audits of the Company’s financial statements according to the standards promulgated by the Public Company Accounting Oversight Board or the Auditing Standards Board.

Between March 23, 2011 and July 8, 2011, China Medicine announced that the Company’s financial statements contained in its Annual Reports filed with the SEC for fiscal years 2006 through 2009 were unreliable, as were the quarterly reports for fiscal years 2006 through 2010.

Take Action

If you purchased China Medicine securities between November 30, 2006 and March 23, 2011, and you would like to discuss your legal rights, visit www.faruqilaw.com/CHME. You can also contact us by calling Anthony Vozzolo toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to avozzolo@faruqilaw.com. Faruqi & Faruqi, LLP also encourages anyone with information regarding China Medicine’s conduct during the period in question to contact the firm, including whistleblowers, former employees, shareholders and others.

About Faruqi & Faruqi, LLP

Faruqi & Faruqi, LLP is a national law firm, representing investors, consumers and companies in the prosecution of claims under state corporate and consumer laws and the federal securities and antitrust laws. Founded in 1995, the firm maintains its principal office in New York City, with offices in Delaware, California, Florida and Pennsylvania. The lawyers at Faruqi & Faruqi, LLP have demonstrated a clear commitment to championing the rights of shareholders and consumers nationwide.

Contact:Faruqi & Faruqi, LLP369 Lexington Avenue, 10th FloorNew York, NY 10017Attn: Anthony Vozzolo, Esq.avozzolo@faruqilaw.comToll Free: (877) 247-4292Phone: (212) 983-9330

Attorney Advertising. (C) 2011 Faruqi & Faruqi, LLP. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We are happy to discuss your particular case.

China Medicine (CE) (USOTC:CHME)
過去株価チャート
から 9 2024 まで 10 2024